PERIODONTAL CONDITION IN PATIENTS WITH BRONCHIAL ASTHMA: INFLUENCE OF THE DISEASE AND ITS PHARMACOTHERAPY
Article Sidebar
Main Article Content
Abstract
Bronchial asthma is a chronic inflammatory condition affecting the respiratory tract, characterized by airway narrowing and excessive mucus production, which leads to difficulty in breathing. A hallmark of this disease is the episodic obstruction of airflow, with the severity of these obstructions varying over short periods. Importantly, these changes are reversible; in some cases, they may resolve spontaneously, while in others, they require medical intervention. Treatment for bronchial asthma primarily involves the use of bronchodilators, corticosteroids, and anticholinergic medications, often administered through inhalation using aerosol dispensers or nebulizers. The effects of these pharmacological treatments on oral health are a subject of considerable discussion among dental professionals. Research indicates that patients who frequently use these medications are at an increased risk of developing dental problems such as cavities, erosive enamel lesions, oral candidiasis, and inflammatory periodontal diseases.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1. Innes DJA, Reid PT. Respiratory diseases. In: Boon NA, Colledge NR, Walker BR, Hunter JAA, editors. Davidson's Principles and Practice of Medicine. 20th ed. Edinburgh: Churchill Livingstone: Elsevier; 2006. p. 670–678.
2. Johansson I, Ericson T. Saliva composition and caries development during protein deficiency and beta-receptor stimulation or inhibition. J Oral Pathol. 1987;16:145–149.
3. Ryberg M, Möller C, Ericson T. Effect of beta 2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children. J Dent Res. 1987;66:1404–1406.
4. Ryberg M, Möller C, Ericson T. Saliva composition and caries development in asthmatic patients treated with beta 2-adrenoceptor agonists: a 4-year follow-up study. Scand J Dent Res. 1991;99:212 218.
5. de Almeida Pdel V, Grégio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008;9:72–80.
6. Steinbacher DM, Glick M. The dental patient with asthma: an update and oral health considerations. J Am Dent Assoc. 2001;132:1229–1239.
7. McDerra EJ, Pollard MA, Curzon ME. The dental status of asthmatic British school children. Pediatr Dent. 1998;20:281–287.
8. Reddy DK, Hegde AM, Munshi AK. Dental caries status of children with bronchial asthma. J Clin Pediatr Dent. 2003;27:293–295.
9. Ersin NK, Gülen F, Eronat N, et al. Oral and dental manifestations of young asthmatics related to medication, severity and duration of condition. Pediatr Int. 2006;48:549–554.
10. Shashikiran ND, Reddy VV, Raju PK. Effect of antiasthmatic medication on dental disease: dental caries and periodontal disease. J Indian Soc Pedod Prev Dent. 2007;25:65–68.
11. Stensson M, Wendt LK, Koch G, Oldaeus G, Birkhed D. Oral health in preschool children with asthma. Int J Paediatr Dent. 2008;18:243–250.
12. Bjerkeborn K, Dahllöf G, Hedlin G, Lindell M, Modéer T. Effect of disease severity and pharmacotherapy of asthma on oral health in asthmatic children. Scand J Dent Res. 1987;95:159 164.